On November 15, 2025, an interregional scientific and practical conference for hematologists, oncologists and clinical pharmacologists on the most pressing problems of oncohematology and hematology was held.
Leading experts made presentations Saratov, Moscow, St. Petersburg, Kaliningrad, Samara.
We would like to express our sincere gratitude to all participants of our conference.
Your contribution and active participation have made this event meaningful and fruitful!!!
The modern development of hematology is happening rapidly. Every year, new data on the molecular mechanisms of the occurrence of hematological neoplasms appear. As a result, the criteria for diagnosis, factors for predicting the development of tumors are changing, innovative targeted drugs are emerging, new therapy regimens and criteria for monitoring it, new approaches to treatment. This requires hematologists to have up-to-date information, and, consequently, continuous training. Here doctors can get the latest knowledge about what is happening in hematology.
Innovation is the future of medicine
Introduction of modern information technologies into various processes of the medical industry, both budgetary and private commercial medicine
Symbiosis of science and clinical practice
The V Moscow International Hematological School of Young Scientists named after S.P. Botkin is an annual scientific conference dedicated to cutting-edge fundamental and clinical research in oncohematology and hematology. The conference will be held in Moscow from February 28 to March 1, 2025, in an international format, in English with simultaneous translation into Russian.
The conference provides young scientists with a unique opportunity to learn and share experiences with peers through an interactive format. The goal of the project is to promote collaboration between hematologists in Russia and other countries. Sessions, including plenary sessions and expert meetings, will be moderated by leading Russian and international experts. Separate educational lectures will be devoted to myeloma, chronic lymphocytic leukemia, myeloproliferative neoplasms, acute leukemia, and CAR-T cell therapy.
The conference will also feature a research paper competition for young scientists and physicians. The best papers will be published in the journal "Clinical Oncohematology," and the winners will be offered the opportunity to participate in person at the EHA 2025 congress.









